Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-10 | New | $7,903,411 | Unknown | Debt Only | SEC link | |
| 2025-02-26 | New | $8,400,000 | $8,400,000 | Debt Only | 06b | SEC link |
| 2024-05-28 | New | $10,775,983 | $10,775,983 | Debt Only | 06b | SEC link |
| 2023-07-24 | New | $9,096,986 | $9,096,986 | Equity Only | 06b | SEC link |
| 2022-12-23 | Amended | $35,012,500 | $9,712,500 | Equity Only | 06b | SEC link |
| 2022-10-04 | New | $2,000,000 | $2,000,000 | Debt Only | 06b | SEC link |
| 2021-05-14 | New | $25,300,000 | $25,300,000 | Equity Only | 06b | SEC link |
| 2021-03-26 | New | $2,000,000 | $2,000,000 | Debt Only | 06b | SEC link |
| 2019-02-15 | New | $3,575,000 | $3,575,000 | Equity Only | 06b | SEC link |
| 2017-01-09 | New | $862,857 | $862,857 | Equity Only | 06b | SEC link |
| 2013-05-29 | New | $1,250,000 | $1,250,000 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Mario Barro | Director |
| James Connolly | Director |
| Ann De Witt | Director |
| Matthew Dirckx | Executive |
| Fenel Eloi | Director |
| Johannes Fruehauf | Director |
| Ted Hibben | Executive |
| Shuenn Ho | Executive |
| Jonathan Kluge | Executive |
| Peter Kolchinsky | Director |
| Kathryn Kosuda | Director, Executive |
| Fiorenzo Omenetto | Director |
| Aaron Sandoski | Director |
| Purnanand Sarma | Director |
| Michael Schrader | Director, Executive |
| Rachel Sha | Director, Executive |
| John Spiridigliozzi | Executive |
| Weiner Tilsner | Executive |
| Mark Tracy | Executive |
| Lynda Tussey | Executive |
| Livio Valenti | Executive |